You are here

Olanzapine

Teva touts safety profile of once-monthly schizophrenia therapy

Clinical Trials Arena

Mon, 09/23/24 - 11:17 am

Teva Parmceuticals

Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3

Fierce Pharma

Tue, 01/31/23 - 12:31 pm

Teva Pharmaceutical

clinical trials

FDA flags safety risks for Lilly antipsychotic drug

BioPharma Dive

Tue, 05/10/16 - 03:06 pm

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

Yahoo

Thu, 01/8/09 - 09:42 am